Loading company
Latest annual · FY2021
Millions- Operating income
- (48)
- Net income
- (49)
- Free cash flow
- (46)
Latest quarter · Q2 FY2022
Millions- Operating income
- (7)
- Net income
- (8)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2016 to FY2021
- n/m
Allena Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$47.6 million | -$32 million | 10-K 2022-03-31 · proof | |
| Net income | -$48.7 million | -$32.8 million | 10-K 2022-03-31 · proof | |
| Cash from operating activities | -$45.7 million | -$28.2 million | 10-K 2022-03-31 · proof | |
| Free cash flow | -$46.3 million | -$28.8 million | 10-K 2022-03-31 · proof | |
| Total assets | $34.8 million | $38.9 million | -10.7% | 10-K 2022-03-31 · proof |
| Total liabilities | $15.9 million | $16.4 million | -2.9% | 10-K 2022-03-31 · proof |
| Cash and cash equivalents | $30 million | $35 million | -14.4% | 10-K 2022-03-31 · proof |
- What was Allena Pharmaceuticals, Inc.'s operating income in fiscal 2021?
- Allena Pharmaceuticals, Inc. reported operating income of -$47.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$32 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What was Allena Pharmaceuticals, Inc.'s net income in fiscal 2021?
- Allena Pharmaceuticals, Inc. reported net income of -$48.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$32.8 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What was Allena Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2021?
- Allena Pharmaceuticals, Inc. reported cash from operating activities of -$45.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$28.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What was Allena Pharmaceuticals, Inc.'s free cash flow in fiscal 2021?
- Allena Pharmaceuticals, Inc. reported free cash flow of -$46.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$28.8 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What are Allena Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2021, Allena Pharmaceuticals, Inc. reported total assets of $34.8 million, against $38.9 million a year earlier (-10.7%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What are Allena Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2021, Allena Pharmaceuticals, Inc. reported total liabilities of $15.9 million, against $16.4 million a year earlier (-2.9%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
- What are Allena Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Allena Pharmaceuticals, Inc. reported cash and cash equivalents of $30 million, against $35 million a year earlier (-14.4%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1624658&period_type=annual&limit=5"Information only, not investment advice.